In Vitro Effects of Strontium on Proliferation and Osteoinduction of Human Preadipocytes

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Nardone, V ^a   Zonefrati, R ^a   Mavilia, C ^a   Romagnoli, C ^a   Ciuffi, S ^a   Fabbri, S ^a   Palmini, G ^a   Galli, G ^a   Tanini, A ^a   Brandi, M L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DICKKOPF 1 PROTEIN; HYDROXYAPATITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; STRONTIUM; STRONTIUM RANELATE; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ADULT; ALP GENE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; BONE REMODELING; CALCIFICATION; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DKK1 GENE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MIDDLE AGED; OSSIFICATION; OSTEOINDUCTION; PPAR GAMMA 2 GENE; PRIORITY JOURNAL; PROADIPOCYTE; QUANTITATIVE ANALYSIS; RUNX2 GENE;

EID: 84937681764     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/871863     Document Type: Article

References (82)

1. J. A. Burdick, M. N. Mason, A. D. Hinman, K. Thorne, and K. S. Anseth, "Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization," Journal of Controlled Release, vol. 83, no. 1, pp. 53-63, 2002.
2. N. K. Garg, S. Gaur, and S. Sharma, "Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture," Acta Orthopaedica Scandinavica, vol. 64, no. 6, pp. 671-672, 1993.
3. N. K. Garg and S. Gaur, "Percutaneous autogenous bonemarrow grafting in congenital tibial pseudarthrosis," The Journal of Bone & Joint Surgery-British Volume, vol. 77, no. 5, pp. 830-831, 1995.
4. J. H. Healey, P. A. Zimmerman, J. M. McDonnell, and J. M. Lane, "Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients," Clinical Orthopaedics and Related Research, no. 256, pp. 280-285, 1990.
5. S. Kadiyala, R. G. Young, M. A. Thiede, and S. P. Bruder, "Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro," Cell Transplantation, vol. 6, no. 2, pp. 125-134, 1997.
6. J. Ringe, C. Kaps, G.-R. Burmester, and M. Sittinger, "Stem cells for regenerative medicine: advances in the engineering of tissues and organs," Naturwissenschaften, vol. 89, no. 8, pp. 338-351, 2002.
7. M. D. Kwan, B. J. Slater, D. C. Wan, andM. T. Longaker, "Cellbased therapies for skeletal regenerative medicine," Human Molecular Genetics, vol. 17, no. 1, pp. R93-R98, 2008.
8. C. Jorgensen, J. Gordeladze, and D. Noel, "Tissue engineering through autologous mesenchymal stem cells," Current Opinion in Biotechnology, vol. 15, no. 5, pp. 406-410, 2004.
9. I. Tognarini, S. Sorace, R. Zonefrati et al., "In vitro differentiation of human mesenchymal stem cells on Ti6Al4V surfaces," Biomaterials, vol. 29, no. 7, pp. 809-824, 2008.
10. T. W. Bauer and G. F. Muschler, "Bone graft materials: an overviewof the basic science," Clinical Orthopaedics and Related Research, no. 371, pp. 10-27, 2000.
11. J. E. Fleming Jr., C. N. Cornell, and G. F. Muschler, "Bone cells and matrices in orthopedic tissue engineering," Orthopedic Clinics of North America, vol. 31, no. 3, pp. 357-374, 2000.
12. K. C. Hicok, T. V. Du Laney, Y. S. Zhou et al., "Human adipose-derived adult stem cells produce osteoid in vivo," Tissue Engineering, vol. 10, no. 3-4, pp. 371-380, 2004.
13. P. Bianco, M. Riminucci, S. Gronthos, and P. G. Robey, "Bone marrow stromal stem cells: nature, biology, and potential applications," Stem Cells, vol. 19, no. 3, pp. 180-192, 2001.
14. P. A. Zuk, M. Zhu, H. Mizuno et al., "Multilineage cells from human adipose tissue: implications for cell-based therapies," Tissue Engineering, vol. 7, no. 2, pp. 211-228, 2001.
15. B. Dawn and R. Bolli, "Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment," Basic Research in Cardiology, vol. 100, no. 6, pp. 494-503, 2005.
16. J. M. Gimble and F. Guilak, "Adipose-derived adult stem cells: isolation, characterization, and differentiation potential," Cytotherapy, vol. 5, no. 5, pp. 362-369, 2003.
17. P. A. Zuk, M. Zhu, P. Ashjian et al., "Human adipose tissue is a source of multipotent stem cells," Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279-4295, 2002.
18. J. M. Gimble, A. J. Katz, and B. A. Bunnell, "Adipose-derived stem cells for regenerative medicine," Circulation Research, vol. 100, no. 9, pp. 1249-1260, 2007.
19. V. Planat-Benard, J.-S. Silvestre, B. Cousin et al., "Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives," Circulation, vol. 109, no. 5, pp. 656-663, 2004.
20. K. M. Safford, K. C. Hicok, S. D. Safford et al., "Neurogenic differentiation of murine and human adipose-derived stromal cells," Biochemical and Biophysical Research Communications, vol. 294, no. 2, pp. 371-379, 2002.
21. M. J. Seo, S. Y. Suh, Y. C. Bae, and J. S. Jung, "Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo," Biochemical and Biophysical Research Communications, vol. 328, no. 1, pp. 258-264, 2005.
22. J. I.Huang, P. A. Zuk,N. F. Jones et al., "Chondrogenic potential of multipotential cells from human adipose tissue," Plastic and Reconstructive Surgery, vol. 113, no. 2, pp. 585-594, 2004.
23. Y. Zhao, H. Lin, J. Zhang et al., "Crosslinked three-dimensional demineralized bone matrix for the adipose-derived stromal cell proliferation and differentiation," Tissue Engineering Part A, vol. 15, no. 1, pp. 13-21, 2009.
24. J. H. Lee, J. W. Rhie, D. Y. Oh, and S. T. Ahn, "Osteogenic differentiation of human adipose tissue-derived stromal cells (hASCs) in a porous three-dimensional scaffold," Biochemical and Biophysical Research Communications, vol. 370, no. 3, pp. 456-460, 2008.
25. E. Gonzalez-Rey, M. A. Gonzalez, N. Varela et al., "Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 241-248, 2010.
26. E. Gonzalez-Rey, P. Anderson, M. A. González, L. Rico, D. Büscher, and M. Delgado, "Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis," Gut, vol. 58, no. 7, pp. 929-939, 2009.
27. L. A.Meza-Zepeda, A. Noer, J. A. Dahl, F.Micci, O.Myklebost, and P. Collas, "High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence: stem cells," Journal of Cellular and Molecular Medicine, vol. 12, no. 2, pp. 553-563, 2008.
28. J. A.Dahl, S.Duggal,N. Coulston et al., "Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous seum or fatal bovine serum," International Journal of Developmental Biology, vol. 52, no. 8, pp. 1033-1042, 2008.
29. S. Gronthos, D. M. Franklin, H. A. Leddy, P. G. Robey, R. W. Storms, and J. M. Gimble, "Surface protein characterization of human adipose tissue-derived stromal cells," Journal of Cellular Physiology, vol. 189, no. 1, pp. 54-63, 2001.
30. M. Witkowska-Zimny and K. Walenko, "Stem cells from adipose tissue," Cellular and Molecular Biology Letters, vol. 16, no. 2, pp. 236-257, 2011.
31. Y. Zhu, T. Liu, K. Song, X. Fan, X. Ma, and Z. Cui, "Adiposederived stem cell: a better stem cell than BMSC," Cell Biochemistry and Function, vol. 26, no. 6, pp. 664-675, 2008.
32. C. Tremolada, G. Palmieri, and C. Ricordi, "Adipocyte transplantation and stem cells: plastic surgery meets regenerative medicine," Cell Transplantation, vol. 19, no. 10, pp. 1217-1223, 2010.
33. G. E. Kilroy, S. J. Foster, X. Wu et al., "Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors," Journal of Cellular Physiology, vol. 212, no. 3, pp. 702-709, 2007.
34. B. Lindroos, R. Suuronen, and S. Miettinen, "The potential of adipose stem cells in regenerative medicine," Stem Cell Reviews and Reports, vol. 7, no. 2, pp. 269-291, 2011.
35. B. Fang, Y. Song, L. Liao, Y. Zhang, and R. C. Zhao, "Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease," Transplantation Proceedings, vol. 39, no. 10, pp. 3358-3362, 2007.
36. B. Fang, Y. Song, Q. Lin et al., "Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children," Pediatric Transplantation, vol. 11, no. 7, pp. 814-817, 2007.
37. B. Fang, Y. Song, R. C. Zhao, Q. Han, and Q. Lin, "Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis," Transplantation Proceedings, vol. 39, no. 5, pp. 1710-1713, 2007.
38. K. Mesimäki, B. Lindroos, J. Törnwall et al., "Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells," International Journal of Oral and Maxillofacial Surgery, vol. 38, no. 3, pp. 201-209, 2009.
39. D. Garcia-Olmo,M. Garcia-Arranz, and D. Herreros, "Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease," Expert Opinion on BiologicalTherapy, vol. 8, no. 9, pp. 1417-1423, 2008.
40. N. H. Riordan, T. E. Ichim, W.-P. Min et al., "Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis," Journal of Translational Medicine, vol. 7, article 29, 2009.
41. K.Yoshimura,K.Sato,N. Aoi,M. Kurita,T.Hirohi, andK.Harii, "Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells," Aesthetic Plastic Surgery, vol. 32, no. 1, pp. 48-55, 2008.
42. K. Yoshimura, K. Sato, N. Aoi et al., "Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells," Dermatologic Surgery, vol. 34, no. 9, pp. 1178-1185, 2008.
43. S. T.Harris,N. B.Watts, H. K.Genant et al., "Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial," The Journal of the AmericanMedical Association, vol. 282, no. 14, pp. 1344-1352, 1999.
44. C. H. Chesnut III, A. Skag, C. Christiansen et al., "Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis," Journal of Bone and Mineral Research, vol. 19, no. 8, pp. 1241-1249, 2004.
45. J. P. Bilezikian, "Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis," American Journal of Medicine, vol. 122, supplement 2, pp. S14-S21, 2009.
46. B. Ettinger, D. M. Black, B. H. Mitlak et al., "Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial," The Journal of the American Medical Association, vol. 282, no. 7, pp. 637-645, 1999.
47. K. E. Ensrud, J. L. Stock, E. Barrett-Connor et al., "Effects of raloxifene on fracture risk in postmenopausal women: the raloxifene use for the heart trial," Journal of Bone and Mineral Research, vol. 23, no. 1, pp. 112-120, 2008.
48. T. Sugimoto, "Osteoporosis treatment by anti-RANKL antibody," Clinical Calcium, vol. 21, no. 8, pp. 1209-1215, 2011.
49. R. A. Adler and R. S. Gill, "Clinical utility of denosumab for treatment of bone loss in men and women," Clinical Interventions in Aging, vol. 6, no. 1, pp. 119-124, 2011.
50. J. Y. Reginster, "Antifracture efficacy of currently available therapies for postmenopausal osteoporosis," Drugs, vol. 71, no. 1, pp. 65-78, 2011.
51. R. M. Neer, C. D. Arnaud, J. R. Zanchetta et al., "Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis," The New England Journal of Medicine, vol. 344, no. 19, pp. 1434-1441, 2001.
52. C. Roux, J. Fechtenbaum, S. Kolta, G. Isaia, J. B. Cannata Andia, and J.-P. Devogelaer, "Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis," Annals of the Rheumatic Diseases, vol. 67, no. 12, pp. 1736-1738, 2008.
53. P. J. Meunier, C. Roux, E. Seeman et al., "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis," The New England Journal of Medicine, vol. 350, no. 5, pp. 459-468, 2004.
54. J. Y. Reginster, E. Seeman,M. C. de Vernejoul et al., "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study," The Journal of Clinical Endocrinology&Metabolism, vol. 90,no. 5, pp. 2816-2822, 2005.
55. P. J. Marie, "Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation," Current Opinion in Rheumatology, vol. 18, no. 1, pp. S11-S15, 2006.
56. P. J.Marie, P. Ammann, G. Boivin, and C. Rey, "Mechanisms of action and therapeutic potential of strontiumin bone," Calcified Tissue International, vol. 69, no. 3, pp. 121-129, 2001.
57. P. J.Marie, "Strontium ranelate: a novelmode of action optimizing bone formation and resorption," Osteoporosis International, vol. 16, no. 1, pp. S7-S10, 2005.
58. S. G. Dahl, P. Allain, P. J. Marie et al., "Incorporation and distribution of strontiumin bone," Bone, vol. 28, no. 4, pp. 446-453, 2001.
59. O. Bruyere, C. Roux, J. Detilleux et al., "Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate," Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3076-3081, 2007.
60. P. J. Marie, M. Hott, D. Modrowski et al., "An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogendeficient rats," Journal of Bone and Mineral Research, vol. 8, no. 5, pp. 607-615, 1993.
61. A. Barbara, P. Delannoy, B. G. Denis, and P. J. Marie, "Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells," Metabolism, vol. 53, no. 4, pp. 532-537, 2004.
62. E. Canalis, M. Hott, P. Deloffre, Y. Tsouderos, and P. J. Marie, "The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro," Bone, vol. 18, no. 6, pp. 517-523, 1996.
63. E. Bonnelye, A. Chabadel, F. Saltel, and P. Jurdic, "Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro," Bone, vol. 42, no. 1, pp. 129-138, 2008.
64. T. C. Brennan, M. S. Rybchyn, W. Green, S. Atwa, A. D. Conigrave, and R. S. Mason, "Osteoblasts play key roles in the mechanisms of action of strontium ranelate," British Journal of Pharmacology, vol. 157, no. 7, pp. 1291-1300, 2009.
65. N. Chattopadhyay, S. J. Quinn,O. Kifor, C. Ye, and E. M. Brown, "The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation," Biochemical Pharmacology, vol. 74, no. 3, pp. 438-447, 2007.
66. L.-L. Zhu, S. Zaidi, Y. Peng et al., "Induction of a program gene expression during osteoblast differentiation with strontium ranelate," Biochemical and Biophysical Research Communications, vol. 355, no. 2, pp. 307-311, 2007.
67. R. Baron and Y. Tsouderos, "In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation," European Journal of Pharmacology, vol. 450, no. 1, pp. 11-17, 2002.
68. N. Takahashi, T. Sasaki, Y. Tsouderos, and T. Suda, "S 12911-2 inhibits osteoclastic bone resorption in vitro," Journal of Bone and Mineral Research, vol. 18, no. 6, pp. 1082-1087, 2003.
69. A. S. Hurtel-Lemaire, R. Mentaverri, A. Caudrillier et al., "The calcium-sensing receptor is involved in strontium ranelateinduced osteoclast apoptosis. New insights into the associated signaling pathways," The Journal of Biological Chemistry, vol. 284, no. 1, pp. 575-584, 2009.
70. P. J.Marie, "Strontium ranelate: new insights into its dual mode of action," Bone, vol. 40, no. 5, pp. S5-S8, 2007.
71. J. E. Fonseca, "Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength," Rheumatology, vol. 47, no. 4, pp. iv17-iv19, 2008.
72. G. J.Atkins, K. J.Welldon, P.Halbout, andD.M.Findlay, "Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response," Osteoporosis International, vol. 20, no. 4, pp. 653-664, 2009.
73. F. Yang, D. Yang, J. Tu, Q. Zheng, L. Cai, and L.Wang, "Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling," Stem Cells, vol. 29, no. 6, pp. 981-991, 2011.
74. Z. Li, Y. Wang, X.-N. Wang, A.-P. Lan, and W. Wu, "Strontium ranelate promotes osteogenic differentiation of rat bonemarrow mesenchymal stem cells by increasing bone morphogenetic protein-7 expression," Nan fang Yi Ke Da Xue Xue Bao, vol. 31, no. 11, pp. 1949-1953, 2011.
75. Y.Li, J. Li, S.Zhu et al., "Effectsof strontiumonproliferationand differentiation of rat bone marrow mesenchymal stem cells," Biochemical and Biophysical Research Communications, vol. 418, no. 4, pp. 725-730, 2012.
76. S. Choudhary, P. Halbout, C. Alander, L. Raisz, and C. Pilbeam, "Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: Involvement of prostaglandins," Journal of Bone and Mineral Research, vol. 22, no. 7, pp. 1002-1010, 2007.
77. F. Yang, J. Tu, D. Yang, G. Li, L. Cai, and L. Wang, "Osteogenic differentiation of mesenchymal stem cells could be enhanced by strontium," Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 2010, pp. 823-826, 2010.
78. M. Sila-Asna, A. Bunyaratvej, S. Maeda, H. Kitaguchi, and N. Bunyaratavej, "Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell," Kobe Journal of Medical Sciences, vol. 53, no. 1, pp. 25-35, 2007.
79. C. Cheng, V. Alt, L. Pan et al., "Preliminary evaluation of different biomaterials for defect healing in an experimental osteoporotic ratmodel with dynamic PET-CT(dPET-CT) using F-18-SodiumFluoride (NaF)," Injury, vol. 45, no. 3, pp. 501-505, 2014.
80. S. C. Verberckmoes, G. J. Behets, L. Oste et al., "Effects of strontium on the physicochemical characteristics of hydroxyapatite," Calcified Tissue International, vol. 75, no. 5, pp. 405-415, 2004.
81. S. C. Verberckmoes, M. E. de Broe, and P. C. D'Haese, "Dosedependent effects of strontium on osteoblast function and mineralization," Kidney International, vol. 64, no. 2, pp. 534-543, 2003.
82. S. Peng, X. S. Liu, T. Wang et al., "In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells," Journal of Orthopaedic Research, vol. 28, no. 9, pp. 1208-1214, 2010.